Privia Health Q3'26 Conference Call - PRIVIA HEALTH GROUP INC

Explicit Guidance:

• 2026 Outlook (Raised above high end of initial guidance):
  • Implemented Providers: Expected to reach 6,000 clinicians by year-end (high end of initial guidance), representing 11.5% growth over 2025.
  • Attributed Lives: Midpoint of new guidance indicates 9.2% growth over 2025.
  • Practice Collections: Projected to grow 13.1% at the midpoint.
  • Care Margins: Projected to grow 16.3% at the midpoint.
  • Adjusted EBITDA: Projected to grow 23.9% at the midpoint.
  • Cash Flow & Balance Sheet: Expects 70% of full-year adjusted EBITDA to convert to free cash flow; targets ending 2026 with at least $520 million in cash (includes impact of American Choice Healthcare transaction and prior MSSP settlements).
  • 2027 Guidance: No material impact on adjusted EBITDA expected from the exit of the Montana partnership ($23M annual collections). The American Choice Healthcare acquisition is expected to positively contribute to attributed lives and adjusted EBITDA in 2027.
• Long-Term Margins: EBITDA margin as a percentage of care margin currently at 28.8%; long-term target range identified as 30%–35%.
• Effective Tax Rate: Expected to be approximately 27% on an ongoing basis.
• Free Cash Flow Conversion: Targeting 70%–75% of EBITDA to FCF on a forward-going basis (accounting for full tax payer status and working capital timing).

Business-Segment Outlook:

• Value-Based Care Footprint: Expanding into 10 existing states and 3 new states via the American Choice Healthcare acquisition, effective January 2027.
• Medicare Advantage (MA): Currently serves 550,000+ MA lives; strategy is to remain "forward-leaning" and increase risk-sharing contracts as the environment stabilizes (post-V28, Star scores, benefit design changes).
• Commercial VBC: Serves 966,000 commercial attributed lives (11.8% growth); focus on expanding density and redesigning contracts with employers/payers to impact cost of care across diverse patient cohorts (pediatric, OB/GYN, pre-Medicare).
• Medicare Shared Savings Program (MSSP) & LEAD: Managing transition from REACH to LEED; close to 340,000 lives in MSSP/REACH/LEED; expects convergence of programs over time and continued performance improvements.
• Ancillary Services: Plans to expand into ambulatory surgery centers (ASCs) and other ancillary lines to lower costs, leveraging the balance sheet for both organic and inorganic expansion.
• Organic Growth Drivers:
  • Existing practice expansion (patient/provider panels).
  • New care center additions within existing markets.
  • Increasing attribution via clinical performance and new contracts.
• New Capabilities: Open to investing in adjacent lines of business, including virtual care, in-home care, and AI-enabled models, pending strategic fit.

Market and Competitive Outlook:

• M&A Environment: Observes a dichotomy where some assets (PE/VC-backed) trade at high multiples, while distressed assets (e.g., Cano/REACH sunset) offer attractive valuations; strategy remains disciplined and opportunistic.
• Industry Consolidation: Anticipates continued consolidation of value-based care entities and physician groups as regulatory changes create disruption; Privia expects to capture market share from underperforming entities and those seeking independence from health system employment.
• Competitive Advantage: Leverages a "single TIN" model and dense medical group networks to differentiate from competitors, aiming to become a leading community-based care delivery network across 50+ specialties.
• TAM Expansion: Total addressable market includes >1 million credential providers; current footprint is a small subset, allowing for years of compounding growth.

Macro / Industry Outlook:

• Physician Fee Schedule (PFS): Initial read on the finalized PFS is "in line with expectations" with no material impact on 2026 or 2027 guidance despite specific ups and downs in puts and takes.
• Regulatory Landscape: Acknowledges disruption from the "One Big Beautiful Act" and attribution shifts, but believes the business model is durable across political cycles.
• CMS Programs: Bullish on long-term Medicare trends (aging population, need for cost management); expects MSSP and LEED programs to evolve and potentially converge.
• Commercial Payers: Payers face pressure but are adjusting; expect continued partnership opportunities for value-based contracts as employers seek cost control.

Strategic Initiatives:

• Acquisitions:
  • American Choice Healthcare MSSP ACO: Acquired for ~$36M cash; covers >36,000 attributed lives; integrates into Privia Care Partners footprint starting Jan 2027.
  • Future M&A: Strong balance sheet ($520M cash) supports ~$800M–$900M in acquisition capacity (debt + cash); evaluating transformational M&A, though with a "high bar."
• Divestitures: Exiting Montana partnership with Surgery Partners effective January 2027; no material financial impact expected.
• Capital Allocation: Evaluating potential capital returns (dividends/buybacks) if internal growth opportunities do not meet the threshold for accretive M&A; current view favors M&A as the primary value driver given the low implied stock multiple.
• Operational Scale: Scaling G&A and operating costs to achieve long-term EBITDA margins of 30%–35%; integrating acquired ACOs using a refined "playbook" to drive density and synergies.

Risks and Headwinds to Outlook:

• Regulatory & CMS Changes: Potential shifts in program structures (MSSP, REACH to LEED), attribution rules, and benefit designs could cause disruption or variance in results.
• Payer Dynamics: Commercial and MA payers may alter contracts, exit markets, or change benefit designs, impacting density and contract economics by state.
• M&A Execution: Integration of acquired assets (e.g., American Choice, Evelyn) carries execution risk; "probabilistic" nature of identifying suitable adjacent assets.
• Economic/Political Sensitivity: While business is historically durable, shifts in administration or "One Big Beautiful Act" impacts could affect provider priorities and market dynamics.
• Cash Flow Timing: Variance in working capital management and timing of MSSP cash settlements may cause temporary deviations from 70%–75% FCF conversion targets.

Management Tone on the Future:

• Confidence Level: High; characterized by "robust momentum," "operational excellence," and "durability." Management explicitly states confidence to "continue to compound growth" for "many years to come."
• Strategic Stance: Aggressive on M&A and expansion ("forward-leaning"), utilizing a strong balance sheet to capture distressed assets; views the current market environment as a "gold rush" for accretive deals.
• Guidance Revisions: Raised guidance across all key metrics (providers, collections, margins, EBITDA) due to strong YTD performance and improved visibility; removed hedges previously necessary in earlier cycles.
• Long-Term View: Bullish on the industry's structural shift toward value-based care; confident in the ability to scale G&A leverage and reach 30%+ EBITDA margins.

Miscellaneous:

• Q&A Specifics: Management noted that the acquisition of a Florida medical group (GAP) explains a temporary acceleration in GAAP revenue vs. care margin, as it shifts from administrative services to full GAAP revenue recognition.
• Stock Compensation: Anticipates GAAP metrics (EPS) to improve over time as stock compensation and public company costs scale more slowly than revenue growth.